Healthcare - Biotechnology - NASDAQ - US
$ 1.13
-1.74 %
$ 5.07 M
Market Cap
-0.97
P/E
CASH FLOW STATEMENT
-3.22 M
OPERATING CASH FLOW
-4.15 M
INVESTING CASH FLOW
-471 K
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Silo Pharma, Inc.
| Net Income | -3.7 M |
| Depreciation & Amortization | 90.1 K |
| Capital Expenditures | -2 |
| Stock-Based Compensation | 104 K |
| Change in Working Capital | 299 K |
| Others | -57.3 K |
| Free Cash Flow | -3.22 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||||
| Net Income | (3.7) | (3.9) | 3.9 | (3.0) | (1.0) | (1.0) | 0.4 | (1.1) | (0.4) | (0.4) | 32.9 K | 39.4 K | 49.8 K |
| Depreciation & Amortization | 90.1 K | 0 | 0.1 | 0.6 | 61.9 K | 17.6 K | 0 | 0 | 8.14 K | 0.2 | 0 | 0 | 0 |
| Deferred Income Tax | 0 | 0 | (0.1) | (0.6) | 61.9 K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation | 0.1 | 0.2 | 0.2 | 1.2 | 0.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Operating Activities | 17.3 K | 0.3 | (7.1) | 0.8 | 0.1 | 1.2 | (0.6) | 1.1 | (0.7) | (0.9) | (0.2) | 0 | 0 |
| Change in Working Capital | 0.3 | 75.3 K | 0.7 | 87.2 K | 82.5 K | 16.8 K | 34.7 K | 89.4 K | 75.8 K | 24.1 K | 18.4 K | 18 K | 3.5 K |
| Cash From Operations | (3.2) | (3.5) | (2.3) | (1.2) | (0.8) | 0.3 | (0.3) | (0.1) | (1.0) | (1.1) | (0.2) | 21.5 K | 46.3 K |
| INVESTING CASH FLOW | |||||||||||||
| Capital Expenditures | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Items | (4.1) | 86.7 K | 7.2 | 39 K | 0.2 | (0.2) | 0.2 | 0.3 | (0.9) | (0.9) | 91.3 K | 0 | 0 |
| Cash From Investing Activities | (4.1) | 86.7 K | 7.2 | 39 K | 0.2 | (0.2) | 0.2 | 0.3 | (0.9) | (0.9) | 91.3 K | 0 | 0 |
| FINANCING CASH FLOW | |||||||||||||
| Common Stock Repurchased | (0.5) | 0 | 0 | 0 | 0 | 2.87 K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 18.9 K | 0.3 | 2.18 K | 0 | 0 | 0 | 15 K | 5 K | 20 K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.25 K | 2.25 K | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 3.8 | 0 | 0.1 | 0 | 0 | 0 | 0 | 33.1 K | 0.2 | 0 | 0 |
| Cash From Financing Activities | (0.5) | 4.9 | 3.8 | 2.1 | 0.4 | 19.5 K | 0 | 0 | 2.25 K | 0.8 | 2.2 | 20 K | 575 |
| CHANGE IN CASH | |||||||||||||
| Net Change In Cash | (7.8) | 1.5 | 8.7 | 1.0 | (0.2) | 42.1 K | (0.3) | (0.1) | (1.0) | (0.3) | 2.0 | 1.47 K | 45.7 K |
| FREE CASH FLOW | |||||||||||||
| Free Cash Flow | (3.2) | (3.5) | (2.3) | (1.2) | (0.8) | 0.3 | (0.3) | (0.1) | (1.0) | (1.1) | (0.2) | 21.5 K | 46.3 K |